第69回日本形成外科学会総会・学術集会 The 69th Annual Meeting of Japan Society of Plastic and Reconstructive Surgery 第69回日本形成外科学会総会・学術集会 The 69th Annual Meeting of Japan Society of Plastic and Reconstructive Surgery

Call for Abstracts of Free Paper

Call for abstracts

Call for abstracts for International Session in the JSPRS2026 Annual Meeting Submission Period
Open: 12:00 pm Monday, September 1, 2025 (JST)
Close: 12:00 pm Wednesday, October 8, 2025 (JST)
Important Dates
Deadline for Abstract Submission October 8, 2025, noon (JST, UTC+9)
Notification of Acceptance (by E-mail) Email will be sent in the beginning of January
・Abstracts should be submitted online.
・All abstract applicants are required to create a user account first.
・Once the submission is completed, a confirmation e-mail will be sent automatically. If you do not receive the confirmation e-mail within 24 hours after submission, please contact the Congress Secretariat (E-mail: jsprs69@jtbcom.co.jp).
・Abstract number will be generated automatically when an abstract is submitted.
・For changes, withdrawal or additional submission, please log in to the system using your ID and password from "Abstract Submission" button at the bottom of this page.
・If you have any questions, please contact the Congress Secretariat. (E-mail: jsprs69@jtbcom.co.jp).

Responsibilities of the Presenting Author

・The first author listed for each abstract serves as the presenting author and as the primary contact for all correspondence regarding the abstract.
・The presenting author must be one of the co-authors listed on the submitted abstract.
・The presenting author is responsible for ensuring that all authors have read the abstract and agreed to be co-authors.

Type of Presentation

Each speaker will have 10 minutes for presentation. Please time your talk for 8 minutes, and 2 minutes for questions and answers.
 *Type of presentation in the JSPRS2026 is only ORAL PRESENTATION.

Abstract Submission Instruction

Your abstract must include:
  • ・Your Name (Name of the First Author)
  • ・Name(s) of Affiliation (This will be printed in the Program Book)
  • ・Name(s) and Affiliation(s) for Co-Authors (up to 8 people)
  • ・Contact E-mail Address
  • ・Title of Abstract (100 one-byte characters)
    The abstract title should be brief and clearly indicate the nature of the presentation. Do not put a period at the end of the title.
  • ・Abstract Body (within 1,600 one-byte characters)
    The entire body of the abstract must not exceed 250 words.
    Spaces are not included in this number. No tables or diagrams should be included.
  • ・Category
    Please select 1 or 2 Categories to your abstract. (Categories will not be printed in the Program Book; they will be used as a reference for peer review.)
Category
01 Aesthetic 14 Head & Neck Reconstruction
02 Aesthetic Breast Surgery 15 Microsurgery / Supermicrosurgery
03 Benign and Malignant Tumors 16 Migraine Surgery
04 Blepharoplasty 17 Laser
05 Breast Reconstruction 18 Liposuction / Body Contouring
06 Burn 19 Lymphedema / Lymphatic Surgery
07 Cell-Based Therapy 20 Otoplasty
08 Chronic Wound 21 Regenerative Medicine
09 Cranio- / Maxillofacial Surgery 22 Rhinoplasty
10 Facial trauma 23 Robotic Surgery
11 Fat grafting 24 Scar / Hypertrophic Scar / Keroid
12 Gender Confirmation Medicine/Surgery, Sex Reassignment Surgery 25 Wound Healing
13 Hand 26 Miscellaneous

Abstract Review and Selection Process

・After the submission deadline, all completed and eligible abstracts will be made available to the Organizing Review Committees for blinded review and scoring, and final decisions will be made in early January 2026.
Incomplete abstracts will not be reviewed.
・All abstracts submitted will be considered eligible for one presentation (ORAL PRESENTATION).

Acceptance / Rejection Notification

・Notification regarding acceptance or rejection of abstracts will be sent to the first (presenting) author in early January 2026 by e-mail; consequently, an accurate e-mail address is critical. Rejection notifications will also be sent at that time.
・If you have not received the e-mail, please contact Congress Secretariat shown at the bottom of this page.

Conflict-Of-Interest (COI) Disclosure Policies

・Conflict-Of-Interest (COI) Policy requires disclosure of any financial or other interest that might be construed as resulting in an actual, potential, or apparent conflict.
・Please disclose any relationships or circumstances that might affect or appear to affect the research presented. These relationships include you or any individual with whom you directly share income.
・All authors and co-authors are required to provide any relevant information concerning personal or professional circumstances and relationships that might reasonably be expected to affect the author's view on the presentation; including relationships with pharmaceutical companies, or other companies whose products or services are related to the subject matter of the presentation topic. If no relevant relationships exist, this must be stated as well.

Abstract Submission

All abstracts should be submitted through the online abstract submission system. Abstract Submission

Inquiries for Abstract Submission

CONGRESS SECRETARIAT
c/o JTB Communication Design, Inc.
8F, JTB Building, 2-1-25 Kyutaro-machi, Chuo-ku, Osaka 541-0056, Japan
TEL: +81-6-4964-8869 FAX: +81-6-4964-8804 E-mail: jsprs69@jtbcom.co.jp

ページトップへ戻る